Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Human Microbiome Market - Growth, Trends and Forecasts to 2022 - Research and Markets

Research and Markets
Posted on: 13 Sep 17

The "Global Human Microbiome Market - Growth, Trends and Forecasts 2017 - 2022" report has been added to Research and Markets' offering.

The global human microbiome market is estimated to be USD 730 million in 2016 and is expected to reach USD 1141 million by 2021, growing at a CAGR of 9.35% during the forecast period.

Over the years, large-scale collaborative projects, such as the NIH Human Microbiome project, have been responsible to generate a holistic understanding of concepts like metagenomics and whole genome sequencing. As human microbiome is currently not well understood, more research collaborations in this field would further contribute to the growth of the market.

Increasing incidence of lifestyle diseases, diarrheal infections, autoimmune disorders, growing geriatric population and advancement in biomedical science are some of the major drivers for the growth of this market. Increased research spending in both the product and technology sectors is a potential driver for the market in the forecast period.

The study of the human microbiome, though still in its infancy, is emerging rapidly as a promising market. However, Lack of comprehensive research, minimal awareness regarding the beneficial use of microbiome-based products and stringent government regulations are turning out to be restraints for the market.

Companies Mentioned:

  • Enterome Bioscience (France)
  • Yakult (Japan)
  • DuPont (U.S.)
  • Metabiomics Corporation (U.S.)
  • ViThera Pharmaceuticals (U.S.)
  • Second Genome Inc. (U.S.)
  • MicroBiome Therapeutics LLC (U.S.)
  • Vedanta BioSciences (U.S.)
  • Osel (U.S.)
  • Merck (U.S.)
  • Others

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry Trends

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

7. Global Human Microbiome Market - Segmentation

8. Global Human Microbiomemarket by Geography - Regional shares and forecast

9. Competitive Landscape

10. Company Profiles

11. Analyst Outlook for Investment Opportunities

12. Future Outlook of the Market

For more information about this report visit https://www.researchandmarkets.com/research/g3zlwr/global_human

View source version on businesswire.com: http://www.businesswire.com/news/home/20170913005570/en/

Business Wire
www.businesswire.com

Last updated on: 13/09/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.